Bulletin
Investor Alert

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 18, 2021, 7:11 p.m.

/zigman2/quotes/203149337/composite

$

516.00

Change

-0.22 -0.04%

Volume

Volume 10,678

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Today's close

$ 523.73

$ 516.22

Change

-7.51 -1.43%

Day low

Day high

$513.68

$523.00

Open

52 week low

52 week high

$441.00

$664.64

Open

Insider Actions for Regeneron Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/07/2021 Marion McCourt
EVP Commercial
1,000   Disposition at $495.63 per share. 495,630
05/07/2021 Marion McCourt
EVP Commercial
1,000   Derivative/Non-derivative trans. at $342.93 per share. 342,930
02/23/2021 P. Roy Vagelos
Director
137,998   Derivative/Non-derivative trans. at $458.48 per share. 63,269,323
02/23/2021 P. Roy Vagelos
Director
248,079   Derivative/Non-derivative trans. at $52.03 per share. 12,907,550
02/23/2021 P. Roy Vagelos
Director
1,921   Derivative/Non-derivative trans. at $52.03 per share. 99,949
02/01/2021 Arthur Frederick Ryan
Director
2   Disposition at $512.82 per share. 1,025
02/01/2021 Arthur Frederick Ryan
Director
4   Disposition at $509.28 per share. 2,037
02/01/2021 Arthur Frederick Ryan
Director
16   Disposition at $508.52 per share. 8,136
02/01/2021 Arthur Frederick Ryan
Director
22   Disposition at $507.39 per share. 11,162
02/01/2021 Arthur Frederick Ryan
Director
30   Disposition at $506.44 per share. 15,193
02/01/2021 Arthur Frederick Ryan
Director
17   Disposition at $505.6 per share. 8,595
02/01/2021 Arthur Frederick Ryan
Director
9   Disposition at $504.68 per share. 4,542
01/25/2021 Michael S. Brown
Director
2,480   Disposition at $554.32 per share. 1,374,713
01/25/2021 Michael S. Brown
Director
2,480   Derivative/Non-derivative trans. at $380.95 per share. 944,756
01/19/2021 P. Roy Vagelos
Director
414   Gift at $0 per share. 0
01/04/2021 George L. Sing
Director
248   Award at $0 per share. 0
01/04/2021 Arthur Frederick Ryan
Director
248   Award at $0 per share. 0
01/04/2021 Michael S. Brown
Director
248   Award at $0 per share. 0
01/04/2021 Joseph L. Goldstein
Director
248   Award at $0 per share. 0
01/04/2021 Marc Tessier-Lavigne
Director
248   Award at $0 per share. 0
01/04/2021 Christine A. Poon
Director
248   Award at $0 per share. 0
01/04/2021 N. Anthony Coles
Director
248   Award at $0 per share. 0
01/04/2021 Huda Y. Zoghbi
Director
248   Award at $0 per share. 0
01/04/2021 Bonnie L. Bassler
Director
248   Award at $0 per share. 0
01/04/2021 Arthur Frederick Ryan
Director
1   Disposition at $491.36 per share. 491
01/04/2021 Arthur Frederick Ryan
Director
4   Disposition at $490.69 per share. 1,962
01/04/2021 Arthur Frederick Ryan
Director
2   Disposition at $489.41 per share. 978
01/04/2021 Arthur Frederick Ryan
Director
5   Disposition at $488.26 per share. 2,441
01/04/2021 Arthur Frederick Ryan
Director
5   Disposition at $487.63 per share. 2,438
01/04/2021 Arthur Frederick Ryan
Director
5   Disposition at $486.77 per share. 2,433
01/04/2021 Arthur Frederick Ryan
Director
12   Disposition at $485.5 per share. 5,826
01/04/2021 Arthur Frederick Ryan
Director
7   Disposition at $484.79 per share. 3,393
01/04/2021 Arthur Frederick Ryan
Director
9   Disposition at $483.37 per share. 4,350
01/04/2021 Arthur Frederick Ryan
Director
13   Disposition at $482.3 per share. 6,269
01/04/2021 Arthur Frederick Ryan
Director
13   Disposition at $481.48 per share. 6,259
01/04/2021 Arthur Frederick Ryan
Director
14   Disposition at $480.57 per share. 6,727
01/04/2021 Arthur Frederick Ryan
Director
5   Disposition at $479.54 per share. 2,397
01/04/2021 Arthur Frederick Ryan
Director
1   Disposition at $478.89 per share. 478
01/04/2021 Arthur Frederick Ryan
Director
4   Disposition at $477.58 per share. 1,910
12/30/2020 George Damis Yancopoulos
President and Chief Scientific; Director
86,096   Derivative/Non-derivative trans. at $483.25 per share. 41,605,892
12/30/2020 George Damis Yancopoulos
President and Chief Scientific; Director
130,714   Derivative/Non-derivative trans. at $483.25 per share. 63,167,540
12/30/2020 George Damis Yancopoulos
President and Chief Scientific; Director
158,079   Derivative/Non-derivative trans. at $52.03 per share. 8,224,850
12/30/2020 George Damis Yancopoulos
President and Chief Scientific; Director
240,000   Derivative/Non-derivative trans. at $52.03 per share. 12,487,200
12/09/2020 P. Roy Vagelos
Director
2,439   Award at $0 per share. 0
12/09/2020 Andrew J. Murphy
EVP Research
1,929   Award at $0 per share. 0
12/09/2020 Andrew J. Murphy
EVP Research
8,285   Award at $0 per share. 0
12/09/2020 Neil Stahl
EVP Research and Development
1,688   Award at $0 per share. 0
12/09/2020 Daniel P. Van Plew
EVP & General Mgr Industrial O
5,000   Award at $0 per share. 0
12/09/2020 Daniel P. Van Plew
EVP & General Mgr Industrial O
1,930   Award at $0 per share. 0
12/09/2020 Christopher Robert Fenimore
VP Controller
1,750   Award at $0 per share. 0
12/09/2020 Christopher Robert Fenimore
VP Controller
969   Award at $0 per share. 0
12/09/2020 Robert E. Landry
EVP Finance CFO
1,930   Award at $0 per share. 0
12/09/2020 Marion McCourt
EVP Commercial
2,000   Award at $0 per share. 0
12/09/2020 Marion McCourt
EVP Commercial
1,075   Award at $0 per share. 0
12/09/2020 Joseph J. LaRosa
EVP General Counsel and Secret
1,930   Award at $0 per share. 0
12/01/2020 Arthur Frederick Ryan
Director
3   Disposition at $524.31 per share. 1,572
12/01/2020 Arthur Frederick Ryan
Director
10   Disposition at $523.32 per share. 5,233
12/01/2020 Arthur Frederick Ryan
Director
14   Disposition at $522.45 per share. 7,314
12/01/2020 Arthur Frederick Ryan
Director
10   Disposition at $521.5 per share. 5,215
12/01/2020 Arthur Frederick Ryan
Director
27   Disposition at $520.58 per share. 14,055
12/01/2020 Arthur Frederick Ryan
Director
13   Disposition at $519.6 per share. 6,754
12/01/2020 Arthur Frederick Ryan
Director
6   Disposition at $518.55 per share. 3,111
12/01/2020 Arthur Frederick Ryan
Director
11   Disposition at $517.63 per share. 5,693
12/01/2020 Arthur Frederick Ryan
Director
4   Disposition at $516.37 per share. 2,065
12/01/2020 Arthur Frederick Ryan
Director
2   Disposition at $515.64 per share. 1,031
11/19/2020 P. Roy Vagelos
Director
2,406   Gift at $0 per share. 0
11/19/2020 P. Roy Vagelos
Director
2,406   Gift at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
3 Purchases
2 Sales
251,000
138,998
Last 6 months
28 Purchases
39 Sales
687,122
361,408
Last 12 months
85 Purchases
449 Sales
1,337,947
1,366,318

Officers and Executives

Dr. P. Roy Vagelos
Chairman
Dr. Leonard S. Schleifer
Co-President, Chief Executive Officer & Director
Dr. George Damis Yancopoulos
Co-President, Director & Chief Scientific Officer
Ms. Patrice Gilooly
Senior VP-Quality Assurance & Operations
Mr. Robert E. Landry
Chief Financial Officer & Executive VP-Finance
Dr. Andrew J. Murphy
Executive Vice President-Research
Mr. Bob McCowan
Chief Information Officer & Senior VP-IT
Dr. Neil Stahl
Executive VP-Research & Development
Dr. David Weinreich
Senior Vice President-Global Clinical Development
Mr. Nouhad Husseini
Vice President-Business Development
Mr. Gerald Underwood
Senior Vice President-Technical Operations
Dr. Kerry K. Reinertsen
Senior Vice President-Strategic Alliances
Mr. Daniel P. Van Plew
EVP, GM-Industrial Operations & Product Supply
Ms. Beth F. Levine
Chief Compliance Officer & Senior Vice President
Dr. Alan Shuldiner
Vice President-Translational Genetics
Ms. Marion McCourt
Senior Vice President & Commercial Head
Mr. Christopher Robert Fenimore
Senior VP, Head-Accounting & Controller
Mr. Justin Holko
Head-Investor Relations
Ms. Sally A. Paull
Senior Vice President-Human Resources
Mr. Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Ms. Maya Bermingham
Senior VP, Public Policy & Government Affairs
Dr. Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety
Dr. Michael S. Brown
Independent Director
Dr. Joseph L. Goldstein
Independent Director
Mr. George L. Sing
Independent Director
Mr. Arthur Frederick Ryan
Independent Director
Ms. Christine A. Poon
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Bonnie L. Bassler
Independent Director
Dr. Huda Y. Zoghbi
Independent Director
Dr. N. Anthony Coles
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.